Balaxi Pharmaceuticals to expand portfolio of proprietary, niche branded formulations

28 Oct 2021 Evaluate

Balaxi Pharmaceuticals has developed a strategy to expand its portfolio of proprietary and niche branded formulations based on the experience that it has gained in the last two years in the Latin American markets. It has decided to invest in establishing in-house capabilities for researching, developing and manufacturing differentiated formulations in these markets with innovative delivery systems.

The Company intends to seek Board approvals to acquire 3-5 acres of land to establish its first manufacturing location near Hyderabad, in the Pharma SEZ, Jadcherla, Telangana. It intends to establish a greenfield WHO-GMP/PICS certified manufacturing facility. This facility will be specifically focusing on expanding the portfolio of differentiated branded formulations.

Balaxi Pharmaceuticals operates as an investment company in India.

Peers
Company Name CMP
Redington 272.00
Adani Enterprises 2239.05
Amrapali Industries 14.95
Rashi Peripheral 345.75
PDS 383.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×